Janney Montgomery Scott LLC Raises Position in The Cooper Companies, Inc. $COO

Janney Montgomery Scott LLC grew its position in The Cooper Companies, Inc. (NASDAQ:COO) by 5.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 97,394 shares of the medical device company’s stock after buying an additional 4,761 shares during the period. Janney Montgomery Scott LLC’s holdings in Cooper Companies were worth $6,931,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of COO. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Cooper Companies by 3.4% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 9,370 shares of the medical device company’s stock valued at $861,000 after purchasing an additional 309 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Cooper Companies by 16.7% during the first quarter. UMB Bank n.a. now owns 902 shares of the medical device company’s stock valued at $76,000 after purchasing an additional 129 shares during the last quarter. Baldwin Wealth Partners LLC MA raised its holdings in shares of Cooper Companies by 44.7% during the first quarter. Baldwin Wealth Partners LLC MA now owns 164,581 shares of the medical device company’s stock valued at $13,882,000 after purchasing an additional 50,862 shares during the last quarter. City Holding Co. purchased a new position in shares of Cooper Companies during the first quarter valued at approximately $34,000. Finally, SG Americas Securities LLC raised its holdings in shares of Cooper Companies by 8,337.0% during the first quarter. SG Americas Securities LLC now owns 369,542 shares of the medical device company’s stock valued at $31,171,000 after purchasing an additional 365,162 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on COO shares. BNP Paribas raised shares of Cooper Companies from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 22nd. Mizuho reduced their target price on shares of Cooper Companies from $105.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, July 16th. Needham & Company LLC reiterated a “buy” rating and set a $94.00 price target on shares of Cooper Companies in a research note on Thursday, August 28th. Stifel Nicolaus cut their price objective on shares of Cooper Companies from $90.00 to $85.00 and set a “buy” rating for the company in a research report on Thursday, August 28th. Finally, BNP Paribas Exane upgraded Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price objective for the company in a research note on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus target price of $84.75.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $70.46 on Monday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The firm has a fifty day moving average price of $69.69 and a 200 day moving average price of $74.07. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $109.37. The firm has a market cap of $14.01 billion, a price-to-earnings ratio of 34.71, a P/E/G ratio of 1.85 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. The firm had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. Cooper Companies’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies announced that its board has initiated a share buyback plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s leadership believes its shares are undervalued.

Insider Activity at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III purchased 10,000 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The shares were bought at an average price of $68.39 per share, with a total value of $683,900.00. Following the completion of the purchase, the chief executive officer directly owned 226,151 shares in the company, valued at $15,466,466.89. This trade represents a 4.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Gerard H. Warner III purchased 1,450 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The shares were acquired at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the purchase, the chief operating officer owned 18,319 shares of the company’s stock, valued at $1,268,224.37. This represents a 8.60% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 17,975 shares of company stock valued at $1,216,346 over the last quarter. 1.98% of the stock is currently owned by insiders.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.